NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 112 filers reported holding NUVALENT INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,021,132 | +2.6% | 22,213 | -5.9% | 0.00% | – |
Q2 2023 | $995,718 | +154.0% | 23,612 | +57.2% | 0.00% | – |
Q1 2023 | $391,950 | +39095.0% | 15,023 | +27720.4% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 54 | -67.1% | 0.00% | – |
Q2 2022 | $2,000 | -96.6% | 164 | -96.1% | 0.00% | – |
Q1 2022 | $59,000 | -49.6% | 4,229 | -31.6% | 0.00% | – |
Q4 2021 | $117,000 | +11600.0% | 6,182 | +11348.1% | 0.00% | – |
Q3 2021 | $1,000 | – | 54 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $436,140,000 | 8.51% |
Fairmount Funds Management LLC | 914,614 | $20,625,000 | 7.50% |
Bain Capital Life Sciences Investors, LLC | 3,428,014 | $77,302,000 | 4.80% |
VR Adviser, LLC | 803,951 | $18,129,000 | 2.33% |
Boxer Capital, LLC | 1,210,192 | $27,290,000 | 0.95% |
BVF INC/IL | 448,512 | $10,114,000 | 0.40% |
Avoro Capital Advisors LLC | 1,257,671 | $22,288,000 | 0.35% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,052,394 | $23,731,000 | 0.28% |
Perceptive Advisors | 750,000 | $16,913,000 | 0.25% |
Logos Global Management LP | 134,650 | $2,733,000 | 0.20% |